Durham VA Medical Center

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Durham VA Medical Center sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials 1 currently recruiting 11 completed top decile by trial count

Durham VA Medical Center: 17 sponsored US clinical trials, 1 recruiting.

Durham VA Medical Center sponsors 17 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 11 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 2 trials.

Top-decile sponsor footprint

Durham VA Medical Center ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

11 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

17 total, page 1 of 1

RECRUITING

The Diabetes Staging System in Patient Aligned Care Teams

NCT06142006

ACTIVE NOT RECRUITING

Telehealth-based Symptom Management for Veterans Treated With Selinexor

NCT06452446

ACTIVE NOT RECRUITING Phase 2

The Medically Reproducing Bariatric Surgery (MRB) II Study

NCT06363747

ACTIVE NOT RECRUITING NA

Telehealth Stepped Exercise Program for Rural Veterans With Knee Osteoarthritis

NCT04775589

NOT YET RECRUITING Phase 4

Veterans Enhanced Recovery Using Integrative Treatments Around Surgery

NCT06333938

COMPLETED Phase 2

Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans

NCT01898013

TERMINATED NA

Blood Pressure, Heart Rate Variability & Sleep in Veterans With PTSD

NCT01920451

COMPLETED NA

Medication Adherence With Polyglot Meducation

NCT01744392

COMPLETED NA

Cholesterol Medication Packaging Study

NCT01744977

COMPLETED NA

Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)

NCT00644423

COMPLETED NA

The Effectiveness of Personalized Stroke Risk Communication

NCT01178060

COMPLETED NA

Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study

NCT00734799

COMPLETED NA

Adjunctive Pregnenolone in Veterans With Mild TBI

NCT00623506

COMPLETED Phase 2

Aripiprazole Augmentation of Antidepressants in PTSD

NCT00489866

COMPLETED NA

Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs

NCT00560781

COMPLETED Phase 4

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

NCT00560612

COMPLETED NA

Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia

NCT00560937

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 4 2

What is open in the Durham VA Medical Center pipeline

1 recruiting of 17 indexed (6% open); 11 completed (65%).

Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).

Top condition: Type 2 Diabetes (2 trials), 8 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Durham VA Medical Center: open-pipeline peers nationwide

Peers matched on 17 registered trials and 6% open enrollment, not the therapeutic-area sidebar.

Durham VA Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 102030405060 0%5%10%15%20%25% Total trials Recruiting share Durham VA Medical CenterAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTecColgate PalmoliveEssentia HealthMadrigal PharmaceuticalsSouthern Methodist University
Durham VA Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Durham VA Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 trials (± recruiting share)

Sponsors near 6% open enrollment (± trial volume)

What to do with this Durham VA Medical Center page

17 registered trials is a research-attention snapshot, not an endorsement of Durham VA Medical Center or any single study.

  • 1 of Durham VA Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Type 2 Diabetes is the condition Durham VA Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Durham VA Medical Center pipeline card: 17 registered trials from official public datasets.Report a data error.